Understanding giant cell sarcoma of the head and neck: A population-based study

Head Neck. 2021 Sep;43(9):2786-2794. doi: 10.1002/hed.26765. Epub 2021 Jun 14.

Abstract

Background: Giant cell sarcomas (GCS) are rare head and neck neoplasms.

Methods: The Surveillance, Epidemiology, and End Results (SEER) database was analyzed for all patients who have been diagnosed with GCS from 1973 to 2014.

Results: Four hundred and forty cases of GCS of the head and neck were identified. The average age at diagnosis was 74.4 years, 86.8% were white, 82.5% were male, 70.7% were insured, and 88.2% lived in an urban metropolitan region. Connective tissue was the most frequent primary site (42.5%). The 5Y-DSS rate was 91.1%, while the 5Y-OS was 54.6% for all cases. Patients treated with surgery alone had the highest 5Y-DSS rate of 94.5. T-classification odds ratio was a significant predictor of survival accounting for confounding variables on multivariate analysis.

Conclusions: GCS presents most frequently in connective tissue of the head and neck with overall high probability of survival. The treatment of choice is surgery alone.

Keywords: head and neck; head and neck chemotherapy; head and neck cutaneous; head and neck radiation therapy; head and neck sarcoma.

MeSH terms

  • Giant Cells
  • Head and Neck Neoplasms* / epidemiology
  • Head and Neck Neoplasms* / surgery
  • Humans
  • Male
  • Retrospective Studies
  • SEER Program
  • Sarcoma*
  • Survival Rate